Your solution to deep vein thrombosis and pulmonary embolism
Innovations & Impacts
The Hydra Catheter Thrombectomy System is a next generation, multi-modal venous thrombectomy device designed to treat acute large-volume DVTs. The device is the first device to overcome the limitations of previous generation devices, all of which lead to significant peri-procedural morbidity and mortality in patients affected by large-volume DVT.
The Hydra Catheter Thrombectomy System combines mechanical, chemical, and suction thrombectomy features for efficient fragmentation and evacuation of venous blood clots, and does so safely by isolating the thrombolytic drugs and thrombus microemboli within a defined treatment zone. The treatment zone is then cleared of these drugs and microemboli before venous flow is restored to the segment. These would improve clinical thrombectomy outcomes while limiting the risk of vein wall trauma, distal microembolization, peri-procedural blood loss.
Competitive Advantage: Using an evidence-based approach, the Hydra Catheter Thrombectomy System device is engineered to be a “next-generation” device. It builds upon our experience with other thrombectomy device categories, and clinical trial outcomes. These indicate that although chemical thrombolysis, mechanical thrombectomy, and negative suction thrombectomy can treat DVT, they are not effective in a single treatment session when applied independently. Additionally, clinical trial findings indicate that current devices are associated with unacceptably high risk of peri-procedural bleeding, vein wall damage, and distal thrombus emboli into the pulmonary arteries. The Hydra Catheter Thrombectomy System device is specifically designed to reduce all of these risks, improve patient outcomes, and enhance the standard of care.